24 Aug 2016 07:00
24 August 2016
Venn Life Sciences Holdings Plc
("Venn" or the "Company")
Notice of results
Investor results presentation
Venn Life Sciences (AIM: VENN), a growing Contract Research Organisation (CRO) providing drug development, clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device clients, announces that it will release its interim results for the six months ended 30 June 2016 on Wednesday 28 September 2016.
Analyst briefing
Tony Richardson, Chief Executive Officer and Jonathan Hartshorn Chief Financial Officer will be hosting a briefing for analysts on Wednesday 28 September 2016 at 10.30am at the offices of Walbrook PR, 4 Lombard St., London EC3V 9HD.
Investor briefing
The management team will also be presenting the Company's financial and operational results for investors on the evening of Wednesday 28 September 2016. The event is open to all investors and will be held at the Black Bar, upstairs at Rocket Bar 6 Adam's Court, Old Broad St, London EC2N 1DX.
To register to attend the analyst briefing or investor briefing, please contact Walbrook PR (details below).
Walbrook PR Limited | Tel: 020 7933 8780 or venn@walbrookpr.com | |
Anna Dunphy | Mob: 07876 741 001 | |
Lianne Cawthorne |
| Mob: 07584 391 303 |
|
| |